van der Laarse A - Search Results

1

Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.

Delsing DJ, Jukema JW, van de Wiel MA, Emeis JJ, van der Laarse A, Havekes LM, Princen HM. Delsing DJ, et al. Among authors: van der laarse a, van de wiel ma. J Cardiovasc Pharmacol. 2003 Jul;42(1):63-70. doi: 10.1097/00005344-200307000-00010. J Cardiovasc Pharmacol. 2003. PMID: 12827028

2

Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice.

van de Poll SW, Delsing DJ, Jukema JW, Princen HM, Havekes LM, Puppels GJ, van der Laarse A. van de Poll SW, et al. Among authors: van der laarse a. Atherosclerosis. 2002 Sep;164(1):65-71. doi: 10.1016/s0021-9150(02)00055-2. Atherosclerosis. 2002. PMID: 12119194

3

Effects of amlodipine, atorvastatin and combination of both on advanced atherosclerotic plaque in APOE*3-Leiden transgenic mice.

van de Poll SW, Delsing DJ, Wouter Jukema J, Princen HM, Havekes LM, Puppels GJ, van der Laarse A. van de Poll SW, et al. Among authors: van der laarse a. J Mol Cell Cardiol. 2003 Jan;35(1):109-18. doi: 10.1016/s0022-2828(02)00284-5. J Mol Cell Cardiol. 2003. PMID: 12623305

4

Current PTCA practice and clinical outcomes in The Netherlands: the real world in the pre-drug-eluting stent era.

Agema WR, Monraats PS, Zwinderman AH, De Winter RJ, Tio RA, Doevendans PA, Waltenberger J, De Maat MP, Frants RR, Atsma DE, Van Der Laarse A, Van Der Wall EE, Jukema JW. Agema WR, et al. Among authors: van der wall ee, van der laarse a. Eur Heart J. 2004 Jul;25(13):1163-70. doi: 10.1016/j.ehj.2004.05.006. Eur Heart J. 2004. PMID: 15231375

5

-455G/A polymorphism and preprocedural plasma levels of fibrinogen show no association with the risk of clinical restenosis in patients with coronary stent placement.

Monraats PS, Rana JS, Zwinderman AH, de Maat MP, Kastelein JP, Agema WR, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: van der wall ee, van der laarse a. Thromb Haemost. 2005 Mar;93(3):564-9. doi: 10.1160/TH04-11-0708. Thromb Haemost. 2005. PMID: 15735811 Clinical Trial.

6

Metabolic syndrome and risk of restenosis in patients undergoing percutaneous coronary intervention.

Rana JS, Monraats PS, Zwinderman AH, de Maat MP, Kastelein JJ, Doevendans PA, de Winter RJ, Tio RA, Frants RR, van der Laarse A, van der Wall EE, Jukema JW; GENDER study. Rana JS, et al. Among authors: van der wall ee, van der laarse a. Diabetes Care. 2005 Apr;28(4):873-7. doi: 10.2337/diacare.28.4.873. Diabetes Care. 2005. PMID: 15793188

7

Effect of intracoronary aqueous oxygen on left ventricular remodeling after anterior wall ST-elevation acute myocardial infarction.

Warda HM, Bax JJ, Bosch JG, Atsma DE, Jukema JW, van der Wall EE, van der Laarse A, Schalij MJ, Oemrawsingh PV. Warda HM, et al. Among authors: van der wall ee, van der laarse a. Am J Cardiol. 2005 Jul 1;96(1):22-4. doi: 10.1016/j.amjcard.2005.02.037. Am J Cardiol. 2005. PMID: 15979426 Clinical Trial.

8

Lipoprotein lipase gene polymorphisms and the risk of target vessel revascularization after percutaneous coronary intervention.

Monraats PS, Rana JS, Nierman MC, Pires NM, Zwinderman AH, Kastelein JJ, Kuivenhoven JA, de Maat MP, Rittersma SZ, Schepers A, Doevendans PA, de Winter RJ, Tio RA, Frants RR, Quax PH, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: van der wall ee, van der laarse a. J Am Coll Cardiol. 2005 Sep 20;46(6):1093-100. doi: 10.1016/j.jacc.2005.05.071. J Am Coll Cardiol. 2005. PMID: 16168296 Free article.

9

Genetic inflammatory factors predict restenosis after percutaneous coronary interventions.

Monraats PS, Pires NM, Agema WR, Zwinderman AH, Schepers A, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, Frants RR, Quax PH, van Vlijmen BJ, Atsma DE, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: van vlijmen bj, van der wall ee, van der laarse a. Circulation. 2005 Oct 18;112(16):2417-25. doi: 10.1161/CIRCULATIONAHA.105.536268. Circulation. 2005. PMID: 16230497

10

Tumor necrosis factor-alpha plays an important role in restenosis development.

Monraats PS, Pires NM, Schepers A, Agema WR, Boesten LS, de Vries MR, Zwinderman AH, de Maat MP, Doevendans PA, de Winter RJ, Tio RA, Waltenberger J, 't Hart LM, Frants RR, Quax PH, van Vlijmen BJ, Havekes LM, van der Laarse A, van der Wall EE, Jukema JW. Monraats PS, et al. Among authors: van vlijmen bj, van der wall ee, van der laarse a. FASEB J. 2005 Dec;19(14):1998-2004. doi: 10.1096/fj.05-4634com. FASEB J. 2005. PMID: 16319143

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

319 results

Search Page